FDA will work with the manufacturers to update the information in the product's labeling. Gestodene is not approved in the United States. These measures will simplify the calculation of the total sodium content of any product prescribed for patients whose sodium intake is restricted. Until these initiatives are completed, this information should be obtained from the manufacturer. A table listing the sodium content of various drug products and formulations is included.
Several factors appear to be important determinants of photic retinal injury.
FDA recommends several actions to reduce the risk of retinal photic injury and reminds physicians about the reporting requirements of the Safe Medical Devices Act of 1990. As has always been recommended, a washout period of at least 14 days should be observed between discontinuing an MAOI and starting Zoloft.